IX.

DRUG STUDY

Classification: Analgesic/ Antipyretic

Generic Name: Paracetamol
Brand Name: Biogesic
Doctors Order: Paracetamol 500 mg 1 tab OD
INDICATION ACTION CONTRAINDICATION SIDE EFFECTS NSG RESPONSIBILITIES

Relief of mild pain or fever -Inhibits the synthesis of -Previous hypersensitivity, -Rash -Assess overall health status and alcohol usage before
prostaglandins that may serve as products containing alcohol, administering paracetamol.
mediators of pain and fever, aspartame, saccharine or
primarily in the CNS. tartrazine should be avoided in -Tell patient not to use for marked fever (higher than 39.5
patients who have º C). Fever persisting longer than 3 days, or recurrent
hypersensitivity or intolerance fever unless directed by prescriber.
to the compunds.
-Avoid giving patient aspirin or aspirin-like analgesics

-Teach client warning signs that needs immediate attention of

the physician.

-Evaluate hepatic, hematologic and renal function

periodically during prolonged, high dose therapy.

26 | P a g e
Classification: Non-steroidal anti-inflammatory drugs (NSAIDs)
Generic Name: Etoricoxib
Brand Name: Arcoxia
Doctors Order: Arcoxia 90 mg 1 tab OD
INDICATION ACTION CONTRAINDICATION SIDE EFFECTS NSG RESPONSIBILITIES

-Short-term treatment -Selectively inhibits Active peptic ulceration -Insomnia -Assess client for history of allergic
of moderate pain for cyclooxygenase- 2 (COX-2) or active gastro-intestinal reaction to Arcoxia or for previous
-Constipation
the symptomatic relief COX-2 which is an isoform of the (GI) bleeding. Patients who heart failure, heart attack, bypass
of osteoarthritis (OA),rheumatoid enzyme that has have -Dizziness surgery, angina, peripheral arterial
arthritis (RA),ankylosing spondylitis, been postulated to be primarily experienced bronchospasm, disease, or transient ischaemic attack.
and the pain and signs of responsible for the synthesis of acute rhinitis, nasal polyps,
-Monitor blood pressure regularly while
inflammation associated with mediators of pain, angio neurotic oedema,
taking this medication.
acute gouty arthritis inflammation, and fever. urticaria, or allergic-type
reactions after taking acetyl -Take medication with a glass of water to
salicylic acid or NSAIDs avoid dehydration. Arcoxia may be
including COX-2inhibitors. taken regardless of food intake.

-Stop the medication immediately

if gastrointestinal lesions occur.

27 | P a g e
Classification: Vitamins
Generic Name: Ascorbic Acid
Brand Name: Vital C
INDICATION ACTION CONTRAINDICATION SIDE EFFECTS NSG RESPONSIBILITIES

-Dietary - Increases -Use of sodium GI: Nausea, vomiting, -Secure doctor’s order
supplement protection ascorbate in heartburn, diarrhea
mechanism of -Do hand washing
patients on
-To prevent the immune CNS:Head ache
sodium -Assess patient’s condition
vitamin C in system, thus restriction;
patients with supporting -Inform patient about the
poor wound healing. -Use of calcium possible side effects of the
nutritional drugs
ascorbate on
habits; patient - Instruct patient to be cautious
receiving of the contraindications of the drugs.
digitalis.
- Return the medication
ticket on the right box for
the next timing.

28 | P a g e
Classification: Lincosamide Antibiotic
Generic Name: Clindamycin
Brand Name: Cleocin
INDICATION ACTION CONTRAINDICATION SIDE EFFECTS NSG RESPONSIBILITIES

-Treatment of serious - Inhibits protein synthesis in -Hypersensitivity to this drug or -Nausea -Assess patient’s infection before and
infections due to susceptible susceptible bacteria, causing lincomycin, tartrazine dye; regularly throughout therapy.
strains. cell death. ulcerative colitis, enteritid. -Vomiting
-Before giving first dose, obtain
-Anorexia specimen for culture and sensitivity
test, begin therapy pending results.
-Monitor renal, hepatic, and
hematopoetic functions during
prolonged therapy.
-Be alert for adverse reactions and
drug interactions.
-If adverse GI reaction occurs, monitor
patients hydration.
-Instruct patient to report diarrhea
and to avoid self-threatening
psudomembranus.
-Tell patient receiving drug IV to
report discomfort at infusion site.

29 | P a g e